Connor, Clark & Lunn Investment Management (CC&L)
IMUX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Immunic IMUX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,003
Closed -$131K – 1592
2025
Q1 		$131K Sell
12,003
-3,914
-25% -$42.3K ﹤0.01% 1346
2024
Q4 		$159K Buy
15,917
+5,691
+56% +$71.7K ﹤0.01% 1345
2024
Q3 		$169K Buy
10,226
+4,239
+71% +$60.4K ﹤0.01% 1338
2024
Q2 		$66.5K Buy
5,987
+33
+0.6% +$410 ﹤0.01% 1325
2024
Q1 		$78.6K Buy
+5,954
New +$77.4K ﹤0.01% 1475
2023
Q4 		– Sell
-2,477
Closed -$36.4K – 1468
2023
Q3 		$36.4K Sell
2,477
-8,274
-77% -$159K ﹤0.01% 1324
2023
Q2 		$270K Buy
10,751
+2,060
+24% +$34.5K ﹤0.01% 1129
2023
Q1 		$129K Buy
+8,691
New +$161K ﹤0.01% 1135

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return